“I’m far from trying to predict what’s going to happen,” UBS chief Sergio P. Ermotti told Semafor’s Liz Hoffman, at the World ...

(Reuters) - The incipient migration of clients from Credit Suisse to UBS should take about another 18 months, UBS CEO Sergio ...

With a focus on cancer and autoimmune conditions, UBS has launched its coverage of 13 small and mid-cap biotechs, noting that ...

UBS lowered the firm’s price target on Moderna (MRNA) to $108 from $140 and keeps a Buy rating on the shares following a model review.

UBS analyst Justin Forsythe maintained a Sell rating on Worldline (0QVI – Research Report) today and set a price target of €5.25. The ...

Let’s dig into how large the upcoming dividends could be. The post Here's the dividend forecast for Rio Tinto shares through ...

Now finally published in the UK, Barbara Kingsolver’s Holding the Line looks at the 1983 Phelps Dodge strike through the women’s eyes ...

Five UBS Wealth Management USA financial advisers based in the firm’s Pacific Desert Market have been named to the Forbes Top ...

Burish attributes much of his group’s success to its stability – Maas may be the only team member who’s been there since he ...

Both Hardin and O’Hara join UBS’s Integra Partners, a private wealth management group led by advisors Vicente Del Rio, Brian ...

Market volatility can be overwhelming, leading some investors to head for the exits and sit in cash. While this seems like a ...

Jim Kosan, financial advisor for ultra high net worth clients, switches from Morgan Stanley to UBS, joins Riverside office. Pat Lizza welcomes him.